evaluation
long
term
tobramycin
therapy
patient
cystic
fibrosis
advanced
pulmonary
disease
nine
cystic
fibrosis
patient
chronic
bronchopulmonary
infection
severely
damaged
lung
invaded
pseudomonas
aeruginosa
eleven
course
prolonged
tobramycin
treatment
mg
kg
day
four
week
administered
pulmonary
symptom
improved
better
quality
life
achieved
one
patient
objective
parameter
chest
x
ray
pulmonary
function
test
changed
lesser
extent
one
patient
pseudomonas
eradicated
sputum
reappeared
discontinuation
therapy
rest
patient
pseudomonas
significantly
suppressed
replaced
pathogen
four
patient
showed
rise
antibody
titre
candida
two
aspergillus
fumigatus
nephrotoxic
side
effect
observed
vestibular
function
reversibly
impaired
one
patient
without
corresponding
clinical
symptom
bacterial
resistance
tobramycin
observed
therapy
